Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Negram (Nalidixic Acid) Caplets & Suspension
Company:  Sanofi-Synthelabo Inc.
Application No.:  014214S050/S051 & 17430s026/S027
Approval Date: 11/23/1999


Date created: August 9, 2004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.